Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06517056 · ClinicalTrials.gov registry record · NA

Emovi 3D Knee Assessment Device Intervention for Operational Readiness

A NA study of Patellofemoral Pain Syndrome and Patellofemoral Pain, sponsored by Womack Army Medical Center.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
2
Study locations

NCT06517056 is a NA study of Patellofemoral Pain Syndrome and Patellofemoral Pain that is actively recruiting participants, run by Womack Army Medical Center. The registered enrollment target is 180 participants, above the 128-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (41% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06517056, a NA study of Patellofemoral Pain Syndrome and Patellofemoral Pain, is actively recruiting participants, sponsored by Womack Army Medical Center.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
2
Study locations

Study Summary

This is a randomized clinical trial investigating the use of the Emovi Knee Kinesiography information in the treatment of anterior knee pain in physical therapy.

Interventions

  • DEVICE Emovi Knee Kinesiography

Study Locations (2)

Hawaii

  • Tripler Army Medical Center - Honolulu

North Carolina

  • Womack Army Medical Center - Fort Liberty

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2024-10-24
Est. Completion 2025-10
Phase NA

Sponsor

Womack Army Medical Center

7 total trials

What the Registry Record Tells You About NCT06517056

The ClinicalTrials.gov registry entry for NCT06517056 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 128-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (41% higher). The listed sponsor is Womack Army Medical Center, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Patellofemoral Pain Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Emovi Knee Kinesiography is the first listed.

NCT06517056 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Hawaii, North Carolina.

Frequently Asked Questions

What is clinical trial NCT06517056 about?

NCT06517056 is a clinical study titled "Emovi 3D Knee Assessment Device Intervention for Operational Readiness". This is a randomized clinical trial investigating the use of the Emovi Knee Kinesiography information in the treatment of anterior knee pain in physical therapy.

What is the current status of trial NCT06517056?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-10-24. Estimated completion is 2025-10.

What conditions does trial NCT06517056 study?

This clinical trial studies the following conditions: Patellofemoral Pain Syndrome, Patellofemoral Pain.

What interventions are being tested in trial NCT06517056?

The interventions under investigation include: Emovi Knee Kinesiography (DEVICE).

Who is sponsoring clinical trial NCT06517056?

This trial is sponsored by Womack Army Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06517056 being conducted?

This trial has 2 study locations across Hawaii, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patellofemoral Pain Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.